Pfizer and Bioentech, seeking US approval to use their Covid-19 jabs during adolescence, have become the first vaccine makers, with officials seeking to bring students back to the classroom as soon as possible in an effort to expand vaccines beyond adults.
On Friday, the agencies said they had requested emergency food approval from the Food and Drug Administration for teenagers between the ages of 12 and 15. Last week, they reported that 2,260 young people between the ages of 12 and 15 were shown a three-step trial of the job. 100 percent effectiveness And a strong antibody response.
The Biotech / Pfizer vaccine is already approved in the U.S. for people over the age of 16, and drug manufacturers say the side effects of this test were “generally consistent” in children aged 16 to 25.
The companies said they planned to request approval from other regulators in the coming days, “representing an important step in the ongoing efforts of Pfizer and Bioentech to support the government in expanding global immunization efforts.”
Vaccinating children can give them more confidence to return to the classroom in large numbers, with many schools currently providing one Mixture Personal and online learning.
In many parts of the United States, schools have been completely or partially closed since the epidemic began because the spread of the infection has prevented teachers and parents from returning to full-face education.
While Pfizer and Bioentech began vaccinating children as young as six months to 11 years old last month, other drug dealers are also at various stages of testing their jobs on children.
Moderner’s trial is underway for children under the age of six months to 12 years, while Johnson and Johnson are making his single-dose shot for 16-year-olds over 12 to 17-year-olds.
This week, there was a trial of the Oxford / AstraZeneca vaccine on children Paused When the UK regulator investigates the connections between job and blood clots in adults.